Comment by: Erik Greve on:
11872 Personality assessment based on the five-factor model of personality structure in patients with primary open-angle glaucoma
Mabuchi F; Yoshimura K; Kashiwagi K et al.
Japanese Journal of Ophthalmology 2005; 49: 31-35

Comment by: Erik Greve on:
11948 Global data on visual impairment in the year 2002
Resnikoff S; Pascolini D; Etya'ale D et al.
Bulletin of the World Health Organisation 2004; 82: 844-851

Comment by: Anja Tuulonen on:
11730 Patient expectations regarding eye care: development and results of the Eye Care Expectations Survey (ECES)
Dawn AG; McGwin G Jr; Lee PP
Archives of Ophthalmology 2005; 123: 534-541

Comment by: Ananth Viswanathan on:
12001 Driving performance of glaucoma patients correlates with peripheral visual field loss
Szlyk JP; Mahler CL; Seiple W et al.
Journal of Glaucoma 2005; 14: 145-150

Comment by: Wallace Alward on:
11744 Molecular basis of Peters anomaly in Saudi Arabia
Edward D; Al Rajhi A; Lewis RA et al.
Ophthalmic Genetics 2004; 25: 257-270

Comment by: Wallace Alward on:
11742 A genetic contribution to intraocular pressure: the beaver dam eye study
Duggal P; Klein AP; Lee KE et al.
Investigative Ophthalmology and Visual Science 2005; 46: 555-560

Comment by: George Cioffi on:
11937 Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma
Prasanna G; Hulet C; Desai D et al.
Pharmacological Research 2005; 51: 41-50

Comment by: Leonard A. Levin on:
11780 Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix
Guo L; Moss SE; Alexander RA et al.
Investigative Ophthalmology and Visual Science 2005; 46: 175-182

Comment by: Ross Ethier on:
11739 Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes
Downs JC; Suh JK; Thomas KA et al.
Investigative Ophthalmology and Visual Science 2005; 46: 540-546

Comment by: Jonathan Crowston on:
11715 Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways
Charles I; Khalyfa A; Kumar DM et al.
Investigative Ophthalmology and Visual Science 2005; 46: 1330-1338

Comment by: Gülgün Tezel on:
12131 Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens
Joachim SC; Pfeiffer N; Grus FH
Graefe's Archive for Clinical and Experimental Ophthalmology 2005; 243: 817-823

Comment by: Ted Acott on:
11746 Effects of interleukin-1β and dexamethasone on the expression of matrix metalloprotease mRNA by trabecular cells exposed to elevated hydrostatic pressure
Ehrich D; Tripathi B; Tripathi R et al.
Acta Ophthalmologica Scandinavica 2005; 83: 104-108

Comment by: Martin Wax on:
11728 Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma
Dan J; Belyea D; Gertner G et al.
Archives of Ophthalmology 2005; 123: 220-224

Comment by: Douglas Johnson on:
12050 Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice
Zillig M; Wurm A; Grehn FJ et al.
Investigative Ophthalmology and Visual Science 2005; 46: 223-234

Comment by: Beatrice Yue on:
12050 Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice
Zillig M; Wurm A; Grehn FJ et al.
Investigative Ophthalmology and Visual Science 2005; 46: 223-234

Comment by: Ernst Tamm on:
11958 Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma
Sacca SC; Pascotto A; Camicione P et al.
Archives of Ophthalmology 2005; 123: 458-463

Comment by: Arthur Weber on:
11870 Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma
Luthra A; Gupta N; Kaufman PL et al.
Experimental Eye Research 2005; 80: 43-49

Comment by: Art Neufeld on:
11926 Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage
Pang IH; Johnson EC; Jia L et al.
Investigative Ophthalmology and Visual Science 2005; 46: 1313-1321

Comment by: Rosario Hernandez on:
11757 Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes
Fuchshofer R; Birke M; Welge-Lussen U et al.
Investigative Ophthalmology and Visual Science 2005; 46: 568-578

Comment by: James Lindsey on:
11757 Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes
Fuchshofer R; Birke M; Welge-Lussen U et al.
Investigative Ophthalmology and Visual Science 2005; 46: 568-578

Comment by: Leonard A. Levin on:
12144 Development and evaluation of psychometric tests of the Chinese-version of low vision quality of life questionnaire
Zou HD; Zhang X; Xu X et al.
Chinese Journal of Ophthalmology 2005; 41: 246-51

Comment by: Michal Schwartz on:
11698 Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat
Blair M; Pease ME; Hammond J et al.
Investigative Ophthalmology and Visual Science 2005; 46: 884-890

Comment by: Leonard A. Levin on:
11969 Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity
Schuettauf F; Vorwerk C; Naskar R et al.
Current Eye Research 2004; 29: 379-386

Comment by: George Cioffi on:
11773 Amelioration of endothelin-1-induced optic nerve head ischemia by topical bunazosin
Goto W; Oku H; Okuno T et al.
Current Eye Research 2005; 30: 81-91

Comment by: Yoshiaki Kitazawa on:
11908 Long-term physiologic changes of intraocular pressure: a 10-year longitudinal analysis in young and middle-aged Japanese men
Nakano T; Tatemichi M; Miura Y et al.
Ophthalmology 2005; 112: 609-616

Comment by: Anastasios Konstas on:
11896 Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients
Mosaed S; Liu JH; Weinreb RN
American Journal of Ophthalmology 2005; 139: 320-324

Comment by: Michael Diestelhorst on:
11705 Reproducibility of self-measured intraocular pressure with the phosphene tonometer in patients with ocular hypertension and early to advanced glaucoma
Brigatti L; Maguluri S
Journal of Glaucoma 2005; 14: 36-39

Comment by: Peter Shah on:
11819 Central corneal thickness and thickness of the lamina cribrosa in human eyes
Jonas JB; Holbach L
Investigative Ophthalmology and Visual Science 2005; 46: 1275-1279

Comment by: Peter Shah on:
11981 Corneal thickness and axial length
Shimmyo M; Orloff PN
American Journal of Ophthalmology 2005; 139: 553-554

Comment by: Peter Shah on:
11793 Relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertensive patients
Henderson PA; Medeiros FA; Zangwill LM et al.
Ophthalmology 2005; 112: 251-256

Comment by: Douglas Anderson on:
11740 Central corneal thickness and vascular risk factors in normal tension glaucoma
Doyle A; Bensaid A; Lachkar Y
Acta Ophthalmologica Scandinavica 2005; 83: 191-195

Comment by: Erik Greve on:
11717 Relation between intraocular pressure and systemic health parameters in Taiwan
Chen HY; Lai SW
Southern Medical Journal 2005; 98: 28-32

Comment by: Anders Heijl on:
11818 Central corneal thickness correlated with glaucoma damage and rate of progression
Jonas JB; Stroux A; Velten I et al.
Investigative Ophthalmology and Visual Science 2005; 46: 1269-1274

Comment by: Erik Greve on:
11821 Clinical implications of peripapillary atrophy in glaucoma
Jonas JB
Current Opinions in Ophthalmology 2005; 16: 84-88

Comment by: Robert Ritch on:
11945 Effects of orbital venous pressure on intraocular pressure and ocular blood flow
Reitsamer HA; Kiel JW
Spektrum der Augenheilkunde 2004; 18: 230-233

Comment by: David Friedman on:
12028 Noncontact goniometry with optical coherence tomography
Wirbelauer C; Karandish A; Haberle H et al.
Archives of Ophthalmology 2005; 123: 179-185

Comment by: David Friedman on:
11771 Anterior chamber width measurement by high-speed optical coherence tomography
Goldsmith JA; Li Y; Chalita MR et al.
Ophthalmology 2005; 112: 238-244

Comment by: Joel Schuman on:
11762 Intraoperative 2-dimensional optical coherence tomography as a new tool for anterior segment surgery
Geerling G; Muller M; Winter C et al.
Archives of Ophthalmology 2005; 123: 253-257

Comment by: Balwantray Chauhan on:
11950 The prevalence of glaucomatous defects with short-wavelength automated perimetry in patients with elevated intraocular pressures
Reus NJ; Colen TP; Lemij HG
Journal of Glaucoma 2005; 14: 26-29

Comment by: Balwantray Chauhan on:
11680 Effect of cataract surgery with intraocular lens implant on frequency doubling perimetry
Arvind H; George R; Baskaran M et al.
Current Eye Research 2005; 30: 123-128

Comment by: Chris Johnson on:
11706 Probing glaucoma visual damage by rarebit perimetry
Brusini P; Salvetat ML; Parisi L et al.
British Journal of Ophthalmology 2005; 89: 180-184

Comment by: Donald Hood on:
12015 Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study
Ventura LM; Porciatti V
Ophthalmology 2005; 112: 20-27

Comment by: Joseph Caprioli on:
11671 Knowledge of chronology of optic disc stereophotographs influences the determination of glaucomatous change
Altangerel U; Bayer A; Henderer JD et al.
Ophthalmology 2005; 112: 40-43

Comment by: Joseph Caprioli on:
11704 Relevance vector machine and support vector machine classifier analysis of scanning laser polarimetry retinal nerve fiber layer measurements
Bowd C; Medeiros FA; Zhang Z et al.
Investigative Ophthalmology and Visual Science 2005; 46: 1322-1329

Comment by: Christian Mardin on:
11704 Relevance vector machine and support vector machine classifier analysis of scanning laser polarimetry retinal nerve fiber layer measurements
Bowd C; Medeiros FA; Zhang Z et al.
Investigative Ophthalmology and Visual Science 2005; 46: 1322-1329

Comment by: David Greenfield on:
11721 Retinal nerve fiber layer measurements do not change after LASIK for high myopia as measured by scanning laser polarimetry with custom compensation
Choplin NT; Schallhorn SC; Sinai M et al.
Ophthalmology 2005; 112: 92-97

Comment by: John Flanagan on:
12031 Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma
Wollstein G; Schuman JS; Price LL et al.
Archives of Ophthalmology 2005; 123: 464-470

Comment by: Alon Harris on:
11722 Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye
Cleary C; Buckley CH; Henry E et al.
British Journal of Ophthalmology 2005; 89: 223-228

Comment by: Douglas Anderson on:
12115 Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure
Takayama J; Tomidokoro A
Investigative Ophthalmology and Visual Science 2005; 46: 1409-1419

Comment by: Catherine Boden on:
11790 Glaucomatous visual field progression with frequency-doubling technology and standard automated perimetry in a longitudinal prospective study
Haymes SA; Hutchison DM; McCormick TA et al.
Investigative Ophthalmology and Visual Science 2005; 46: 547-554

Comment by: Tin Aung on:
11959 Uveal effusion in primary angle-closure glaucoma
Sakai H; Morine-Shinjyo S; Shinzato M et al.
Ophthalmology 2005; 112: 413-419

Comment by: Stefano Miglior on:
11778 Risk of glaucoma in ocular hypertension with and without pseudoexfoliation
Grodum K; Heijl A; Bengtsson B
Ophthalmology 2005; 112: 386-390

Comment by: Richard Parrish II on:
11885 Results of the European Glaucoma Prevention Study
Miglior S; Zeyen T; Pfeiffer N et al.
Ophthalmology 2005; 112: 366-375

Comment by: Tetsuya Yamamoto on:
11885 Results of the European Glaucoma Prevention Study
Miglior S; Zeyen T; Pfeiffer N et al.
Ophthalmology 2005; 112: 366-375

Comment by: Richard Parrish II on:
12114 A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension
Bengtsson B; Heijl A
Journal of Glaucoma 2005; 14: 135-138

Comment by: Erik Greve on:
12041 New therapies for glaucoma: Are they all up to the task?
Yorio T; Dibas A
Expert Opinion on Therapeutic Patents 2004; 14: 1743-1762

Comment by: Donald Minckler on:
11923 Alphagan allergy may increase the propensity for multiple eye-drop allergy
Osborne SA; Montgomery DMI; Morris D et al.
Eye 2005; 19: 129-137

Comment by: Donald Minckler on:
11713 Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States
Camras CB; Sheu WP; United States Latanoprost-Brimonidine Study Group
Journal of Glaucoma 2005; 14: 161-167

Comment by: Carl Camras on:
11678 Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial
Arcieri ES; Santana A; Rocha FN et al.
Archives of Ophthalmology 2005; 123: 186-192

Comment by: Richard Lewis on:
12007 Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification
Traverso CE; De Feo F; Messas-Kaplan A et al.
British Journal of Ophthalmology 2005; 89: 425-429

Comment by: Richard Lewis on:
11727 Implantation of a miniature glaucoma device under a scleral flap
Dahan E; Carmichael TR
Journal of Glaucoma 2005; 14: 98-102

Comment by: Erik Greve on:
11825 2002 Survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use
Joshi AB; Parrish RK 2nd; Feuer WF
Journal of Glaucoma 2005; 14: 172-174

Comment by: Mark Sherwood on:
11817 Adenoviral p53 gene transfer inhibits human Tenon's capsule fibroblast proliferation
Johnson KT; Rodicker F; Heise K et al.
British Journal of Ophthalmology 2005; 89: 508-512